{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:55:22Z","timestamp":1789602922920,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005881","name":"Emberi Eroforr\u00e1sok Miniszt\u00e9riuma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jpba.2020.113246","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T12:39:14Z","timestamp":1583757554000},"page":"113246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["A validated UHPLC-MS method for tryptophan metabolites: Application in the diagnosis of multiple sclerosis"],"prefix":"10.1016","volume":"185","author":[{"given":"Ferenc","family":"T\u00f6m\u00f6si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Kecskem\u00e9ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina Katalin","family":"Cseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elza","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia","family":"Rajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"Korm\u00e1ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Jan\u00e1ky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113246_bib0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpba.2020.113246_bib0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1582-4934.2010.01237.x","article-title":"Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines","volume":"15","author":"Z\u00e1dori","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jpba.2020.113246_bib0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpba.2020.113246_bib0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.msard.2015.04.006","article-title":"Is it time to target no evident disease activity (NEDA) in multiple sclerosis?","volume":"4","author":"Giovannoni","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jpba.2020.113246_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020426","article-title":"Exploiting the therapeutic potential of endogenous immunomodulatory systems in multiple sclerosis\u2014 special focus on the peroxisome proliferator-activated receptors (PPARs) and the kynurenines","volume":"20","author":"Fakan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2020.113246_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbi.2015.07.016","article-title":"Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms","volume":"51","author":"Aeinehband","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpba.2020.113246_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0304-3940(02)00710-3","article-title":"Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients","volume":"331","author":"Rejdak","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpba.2020.113246_bib0040","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2020.113246_bib0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chroma.2016.02.009","article-title":"Stable isotope dilution ultra-high performance liquid chromatography-tandem mass spectrometry quantitative profiling of tryptophan-related neuroactive substances in human serum and cerebrospinal fluid","volume":"1437","author":"H\u00e9nykov\u00e1","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2020.113246_bib0050","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.4155\/bio-2016-0111","article-title":"LC-MS\/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain","volume":"8","author":"Fuertig","year":"2016","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jpba.2020.113246_bib0055","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1007\/s00216-011-5436-y","article-title":"Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography-tandem mass spectrometry","volume":"401","author":"Zhu","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2020.113246_bib0060","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jpba.2017.05.006","article-title":"An overview of experimental designs in HPLC method development and validation","volume":"147","author":"Sahu","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113246_bib0065","doi-asserted-by":"crossref","unstructured":"S. Fekete, I. Moln\u00e1r, H.-J. Rieger, R. Korm\u00e1ny. 2018. HPLC method development by QbD compatible resolution modeling (DryLab4), in: Software-assisted method development in high performance liquid chromatography, World Scientific (Europe) see: https:\/\/www.worldscientific.com\/doi\/abs\/10.1142\/97817; 11-51.","DOI":"10.1142\/9781786345462_0002"},{"key":"10.1016\/j.jpba.2020.113246_bib0070","unstructured":"Brain slice electrophysiology | Protocol | Abcam, (2018). https:\/\/www.abcam.com\/protocols\/brain-slice-electrophysiology-video-protocol (accessed September 17, 2019)."},{"key":"10.1016\/j.jpba.2020.113246_bib0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jchromb.2012.04.030","article-title":"Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma","volume":"898","author":"M\u00f6ller","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2020.113246_bib0080","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.jpba.2020.113246_bib0085","series-title":"Q2(R1) Validation of Analytical Procedures, in: ICH Qual. Guidel","first-page":"127","author":"Borman","year":"2017"},{"key":"10.1016\/j.jpba.2020.113246_bib0090","series-title":"Bioanalytical Method Validation Guidance for Industry","author":"FDA CDER","year":"2018"},{"key":"10.1016\/j.jpba.2020.113246_bib0095","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/mas.20298","article-title":"An overview of matrix effects in liquid chromatography-mass spectrometry","volume":"30","author":"Trufelli","year":"2011","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jpba.2020.113246_bib0100","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2019"},{"key":"10.1016\/j.jpba.2020.113246_bib0105","series-title":"Handbook in Separation Science: Liquid Chromatography","article-title":"Derivatization in liquid chromatography","author":"Fanali","year":"2017"},{"key":"10.1016\/j.jpba.2020.113246_bib0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/clinchem\/39.1.66","article-title":"Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry","volume":"39","author":"Chace","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2020.113246_bib0115","first-page":"92","article-title":"Mechanisms of interaction responsible for alternative selectivity of fluorinated stationary phases","volume":"34","author":"Bell","year":"2016","journal-title":"LCGC North Am."},{"key":"10.1016\/j.jpba.2020.113246_bib0120","unstructured":"Chemicalize - Instant Cheminformatics Solutions, (n.d.). https:\/\/chemicalize.com\/ (accessed November 8, 2019)."},{"key":"10.1016\/j.jpba.2020.113246_bib0125","unstructured":"DryLab\u00ae Publications, 2019. http:\/\/molnar-institute.com\/fileadmin\/user_upload\/Publication_List.pdf (accessed November 12, 2019)."},{"key":"10.1016\/j.jpba.2020.113246_bib0130","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1039\/C5AY00308C","article-title":"Simultaneous determination of multiple neurotransmitters and their metabolites in rat brain homogenates and microdialysates by LC-MS\/MS","volume":"7","author":"Zhang","year":"2015","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jpba.2020.113246_bib0135","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00552","article-title":"The metabolic factor kynurenic acid of kynurenine pathway predicts major depressive disorder","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpba.2020.113246_bib0140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuropharm.2016.01.034","article-title":"Kynurenine pathway metabolites and suicidality","volume":"112","author":"Bryleva","year":"2017","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.jpba.2020.113246_bib0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yexcr.2014.02.024","article-title":"The phosphorylation status and cytoskeletal remodeling of striatal astrocytes treated with quinolinic acid","volume":"322","author":"Pierozan","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jpba.2020.113246_bib0150","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum Neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann. Neurol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519330092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519330092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:04:05Z","timestamp":1760000645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708519330092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":30,"alternative-id":["S0731708519330092"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113246","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A validated UHPLC-MS method for tryptophan metabolites: Application in the diagnosis of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113246"}}